default author photo

Liton Kumar Saha

Government of the United States of America - Developmental Therapeutics Branch & Laboratory of Molecular Pharmacology

Bethesda, MD 20892

United States

  • Government of the United States of America - Developmental Therapeutics Branch & Laboratory of Molecular Pharmacology

SCHOLARLY PAPERS

2

DOWNLOADS

91

TOTAL CITATIONS

1

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Resolution of R-Loops by Topoisomerase III-β (TOP3B) in Coordination With the DEAD-Box Helicase DDX5

Number of pages: 50 Posted: 28 Feb 2022
Sourav Saha, Xi Yang, Shar-Yin Huang, Keli Agama, Simone Andrea Baechler, Yilun Sun, Hongliang Zhang, Liton Kumar Saha, Shuaikun Su, Lisa M. Jenkins, Weidong Wang and Yves Pommier
Government of the United States of America - Developmental Therapeutics Branch & Laboratory of Molecular Pharmacology, Government of the United States of America - Developmental Therapeutics Branch & Laboratory of Molecular Pharmacology, Government of the United States of America - Developmental Therapeutics Branch & Laboratory of Molecular Pharmacology, Government of the United States of America - Developmental Therapeutics Branch & Laboratory of Molecular Pharmacology, Government of the United States of America - Developmental Therapeutics Branch & Laboratory of Molecular Pharmacology, Government of the United States of America - Developmental Therapeutics Branch & Laboratory of Molecular Pharmacology, Government of the United States of America - Developmental Therapeutics Branch & Laboratory of Molecular Pharmacology, Government of the United States of America - Developmental Therapeutics Branch & Laboratory of Molecular Pharmacology, Government of the United States of America - Laboratory of Genetics and Genomics, Government of the United States of America - Collaborative Protein Technology Resource, Government of the United States of America - Laboratory of Genetics and Genomics and Center for Cancer Research, National Cancer Institute, NIH, Bethesda
Downloads 54 (1,020,567)
Citation 1

Abstract:

Loading...

R-loop, DNA-RNA hybrids, DNA/ RNA Topoisomerase 3B, Topoisomerase cleavage complexes, DDX5, Senataxin, TDRD3

2.

ATR Inhibition Augments the Efficacy of Lurbinectedin in Small Cell Lung Cancer

Number of pages: 45 Posted: 13 Apr 2022
Christopher Schultz, Yang Zhang, Rajaa Elmeskini, Astrid Zimmermann, Haiqing Fu, Yasuhisa Murai, Darawalee Wangsa, Suresh Kumar, Nobuyuki Takahashi, Devon Atkinson, Liton Kumar Saha, Chien-Fei Lee, Brian Elenbaas, Parth Desai, Robin Sebastian, Thomas Ried, Mirit I. Aladjem, Frank T. Zenke, Zoe Weaver, Yves Pommier and Anish Thomas
National Institutes of Health - Developmental Therapeutics Branch, Government of the United States of America - National Cancer Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, National Institutes of Health - Developmental Therapeutics Branch, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, affiliation not provided to SSRN, Government of the United States of America - Developmental Therapeutics Branch & Laboratory of Molecular Pharmacology, affiliation not provided to SSRN, affiliation not provided to SSRN, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, National Institutes of Health - Developmental Therapeutics Branch, affiliation not provided to SSRN, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute and National Institutes of Health - Developmental Therapeutics Branch
Downloads 37 (1,222,651)

Abstract:

Loading...

Small Cell Lung Cancer, Lung Cancer, SCLC, Translational, Pre-clinical, synergy, combination, Biomarkers, ATR inhibitor, lurbinectedin, DNA-damage, cell-cycle